<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02315170</url>
  </required_header>
  <id_info>
    <org_study_id>rkm006</org_study_id>
    <nct_id>NCT02315170</nct_id>
  </id_info>
  <brief_title>Assessment of Novel Intraocular Injection Guide</brief_title>
  <official_title>Assessment of Novel Intraocular Injection Guide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maturi, Raj K., M.D., P.C.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maturi, Raj K., M.D., P.C.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if a novel intraocular injection guide (IIG) reduces patient discomfort during
      and after intravitreal injections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is being conducted to assess the potential for an intraocular injection guide to
      increase comfort levels both during and after such injections. The hypothesis is that
      patients will feel increased comfort from a device which eliminates the need for a speculum
      while still keeping the eyelids apart, allowing a physician to deliver treatment. The results
      of this study will allow physicians to select the optimal device for patient comfort and
      well-being during intravitreal injections
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS)</measure>
    <time_frame>4 months</time_frame>
    <description>The VAS is a horizontal line anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current state (no pain to very severe pain)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Retinal Disease</condition>
  <arm_group>
    <arm_group_label>intraocular injection guide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>novel intraocular injection guide is a long, tubular structure consisting of a non-moldable material with a single internal opening. There is a 2x2 square hole located at the bottom of the device where the needle exits the guide and enters the eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard lid speculum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard wire eyelid speculum</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intraocular injection guide</intervention_name>
    <description>The device is 35mm long with tapered edges for an easy grip and it aligns with the curvature of the cornea to ensure that needle entry takes place at the optimal distance for injection</description>
    <arm_group_label>intraocular injection guide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>standard lid speculum</intervention_name>
    <description>standard wire lid speculum</description>
    <arm_group_label>standard lid speculum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be receiving bilateral injections of the same dose of vascular
             endothelial growth factor (VEGF) inhibitor

          -  Injections in both eyes must be given on the same day

          -  Male or female age 18 years or older

        Exclusion Criteria:

        -Any condition or reason that precludes the subject's ability to comply with the study -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raj K Maturi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Raj K. Maturi, MD, PC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Raj K Maturi MD PC</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>December 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2014</study_first_posted>
  <last_update_submitted>February 2, 2015</last_update_submitted>
  <last_update_submitted_qc>February 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maturi, Raj K., M.D., P.C.</investigator_affiliation>
    <investigator_full_name>Raj K. Maturi, MD</investigator_full_name>
    <investigator_title>President</investigator_title>
  </responsible_party>
  <keyword>diabetic retinopathy</keyword>
  <keyword>age-related macular edema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

